RSV Vaccine Shortage: CDC's Guidelines and Challenges for Parents
The Centers for Disease Control and Prevention (CDC) has advised doctors to prioritize the limited supply of the new infant RSV immunization, Beyfortus, for infants under 6 months old or those with underlying conditions. The shortage has led to the inability to provide the immunization to all eligible infants, causing disappointment among doctors and parents. The CDC recommends promoting RSV vaccination in pregnant women to pass on antibodies to their infants. In the absence of the immunization, everyday preventive measures such as handwashing and staying home when sick are advised. The shortage raises concerns about unprotected infants and the potential for severe RSV disease.